Intra-Day Trading Update: Vivus Showing Significant Strength

Shares of Vivus, Inc.

are really rocking and rolling during Friday's trading session. After opening the day slightly higher, VVUS shares have surged 12% to $20.93 on extremely heavy volume. Yesterday, the stock rose more than 77% after an FDA panel voted to recommend the company's Qnexa weight loss drug by a 20-2 margin. Analysts across Wall Street have been aggressively moving price targets higher in the wake of the overwhelmingly positive FDA panel decision. While the recommendation is not binding in the FDA's decision, it is extremely likely that Qnexa will gain approval.